Help us: Donate
Follow us on:

Tag: Intervene Immune

EARD2021 Greg Fahy
At Ending Age-Related Diseases 2021, Greg Fahy discussed TRIIM-X, the ongoing continuation of his original TRIIM trial, along with some surprising findings from it. Script I'm just going to try to update everybody on the TRIIM-X clinical trial. I will explain where that came from, just to make sure everybody has the same background in...
Greg Fahy
Dr. Greg Fahy, Chief Scientific Officer of Intervene Immune, has recently appeared on The Damage Report, a news and current events show that is part of The Young Turks (TYT) network. Hosts John Iadarola and Brooke Thomas talked with Dr. Fahy about the recent positive results of his company's human clinical trial for thymus rejuvenation....
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech. We will be bringing you the latest aging research, investment, and business knowledge from some of the top...

Want the latest longevity news? Subscribe to our Newsletter!